Summary
World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.
Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.
XYZResearch's analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.
This research report indicated that the global Point of Care (PoC) Molecular Diagnostics market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Point of Care (PoC) Molecular Diagnostics Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Point of Care (PoC) Molecular Diagnostics Market?
Bayer Corporation
Roche Diagnostics
Sysmex Corporation
Abaxis
Abbott Laboratories
BioMerieux SA
Bio-Rad Laboratories
Danaher Corporation
OraSure Technologies
...
Major Type of Point of Care (PoC) Molecular Diagnostics Covered in XYZResearch report:
Polymerase Chain Reaction (Real Time PCR)
In Situ Hybridization
Chips and Microarrays
Mass Spectrometry
Sequencing
Isothermal Amplification
Others
Application Segments Covered in XYZResearch Market
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Point of Care (PoC) Molecular Diagnostics Market 2015-2026, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Polymerase Chain Reaction (Real Time PCR) -Product Introduction and Major Manufacturers
1.1.2 In Situ Hybridization -Product Introduction and Major Manufacturers
1.1.3 Chips and Microarrays -Product Introduction and Major Manufacturers
1.1.4 Mass Spectrometry -Product Introduction and Major Manufacturers
1.1.5 Sequencing -Product Introduction and Major Manufacturers
1.1.6 Isothermal Amplification -Product Introduction and Major Manufacturers
1.1.7 Others -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Regional Market Analysis
2.1 China Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.1.1 China Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.1.2 China Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.2 EU Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.2.1 EU Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.2.2 EU Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.3 USA Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.3.1 USA Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.3.2 USA Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.4 Japan Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.4.1 Japan Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.4.2 Japan Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.5 India Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.5.1 India Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.5.2 India Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.6 Southeast Asia Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.6.1 Southeast Asia Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.6.2 Southeast Asia Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.7 South America Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.7.1 South America Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.7.2 South America Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
2.8 Point of Care (PoC) Molecular Diagnostics Status and Prospect (2015-2026)
2.8.1 Point of Care (PoC) Molecular Diagnostics Market Size and Growth Rate (2015-2026)
2.8.2 Point of Care (PoC) Molecular Diagnostics Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
3 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Segment
3.1 Global Point of Care (PoC) Molecular Diagnostics Capacity and Growth Rate
3.2 Global Point of Care (PoC) Molecular Diagnostics Sales by Type
3.3 Global Point of Care (PoC) Molecular Diagnostics Sales Revenue by Type
3.4 Global Point of Care (PoC) Molecular Diagnostics Consumption by Application
4 Global Point of Care (PoC) Molecular Diagnostics Market Assessment by Regions
4.1 Global Point of Care (PoC) Molecular Diagnostics Production Analysis and Forecast by Regions (2015-2026)
4.2 Global Point of Care (PoC) Molecular Diagnostics Sales Analysis and Forecast by Regions (2015-2026)
4.3 Global Point of Care (PoC) Molecular Diagnostics Sales Revenue Analysis and Forecast by Regions (2015-2026)
5 Value Chain (Impact of COVID-19)
5.1 Point of Care (PoC) Molecular Diagnostics Value Chain Analysis
5.1.1 Upstream
5.1.2 Downstream
5.2 COVID-19 Impact on Point of Care (PoC) Molecular Diagnostics Industry
5.2.1 Industrial Policy Issued Under the Epidemic Situation
5.3 Cost-Under the Epidemic Situation
5.3.1 Cost of Raw Material
5.4 Channel Analysis
5.4.1 Distribution Channel-Under the Epidemic Situation
5.4.2 Distributors
6 Competitive Landscape
6.1 Global Point of Care (PoC) Molecular Diagnostics Capacity Market Share of Manufacturers (2019-2020)
6.2 Global Point of Care (PoC) Molecular Diagnostics Sales Market Share of Manufacturers (2019-2020)
6.3 Global Point of Care (PoC) Molecular Diagnostics Sales Revenue Market Share of Manufacturers (2019-2020)
7 Point of Care (PoC) Molecular Diagnostics Competitive Analysis
7.1 Bayer Corporation
7.1.1 Bayer Corporation Company Profiles
7.1.2 Bayer Corporation Product Introduction
7.1.3 Bayer Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.1.4 SWOT Analysis
7.2 Roche Diagnostics
7.2.1 Roche Diagnostics Company Profiles
7.2.2 Roche Diagnostics Product Introduction
7.2.3 Roche Diagnostics Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.2.4 SWOT Analysis
7.3 Sysmex Corporation
7.3.1 Sysmex Corporation Company Profiles
7.3.2 Sysmex Corporation Product Introduction
7.3.3 Sysmex Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.3.4 SWOT Analysis
7.4 Abaxis
7.4.1 Abaxis Company Profiles
7.4.2 Abaxis Product Introduction
7.4.3 Abaxis Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.4.4 SWOT Analysis
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Profiles
7.5.2 Abbott Laboratories Product Introduction
7.5.3 Abbott Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.5.4 SWOT Analysis
7.6 BioMerieux SA
7.6.1 BioMerieux SA Company Profiles
7.6.2 BioMerieux SA Product Introduction
7.6.3 BioMerieux SA Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.6.4 SWOT Analysis
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Profiles
7.7.2 Bio-Rad Laboratories Product Introduction
7.7.3 Bio-Rad Laboratories Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.7.4 SWOT Analysis
7.8 Danaher Corporation
7.8.1 Danaher Corporation Company Profiles
7.8.2 Danaher Corporation Product Introduction
7.8.3 Danaher Corporation Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.8.4 SWOT Analysis
7.9 OraSure Technologies
7.9.1 OraSure Technologies Company Profiles
7.9.2 OraSure Technologies Product Introduction
7.9.3 OraSure Technologies Point of Care (PoC) Molecular Diagnostics Production, Revenue (2015-2020)
7.9.4 SWOT Analysis
8 Conclusion
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Electronics |
Pages : 206 |
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Telecom and IT |
Pages : 213 |